John Carpten, when he was named director of the City of Hope Comprehensive Cancer Center in April, took over a massive, newly formed national oncology network—the first of its kind.
A year ago, Renee Wegrzyn signed up for a very cool job. As the inaugural director of the Advanced Research Projects Agency for Health, she was to prove that the nontraditional, $2.5 billion experiment will yield the kind of high impact its high-risk investment model promises. Since Wegrzyn joined the agency in October 2022, ARPA-H has […]
The University of Kentucky Markey Cancer Center received NCI’s Comprehensive designation just 10 whip-fast years after the center received its initial Cancer Center designation.
The American Association for Cancer Research has established the AACR Cancer Centers Alliance to foster collaboration between cancer centers.
Montefiore Einstein Cancer Center can now add the word “Comprehensive” to its logo.
Shelton “Shelley” Earp said he will step down as director of the UNC Lineberger Comprehensive Cancer Center effective June 2024.
Crystal S. Denlinger was named CEO of the National Comprehensive Cancer Network.
When John Laszlo joined the Acute Leukemia Service at NCI in 1956, the field of oncology was nascent—and the cure for childhood leukemia seemed beyond reach.
Fifteen years ago, after the death of his favorite uncle, Steven Rosen committed his grief to paper.
A mainstay of cancer treatment, doxorubicin is used as a standalone agent or in combination therapies, on-label and off, in at least 14 cancer types, including breast cancer, non-small cell lung cancer, and Wilms tumor.
